Eculizumab biosimilar Elizaria demonstrates long-term safety and efficacy comparable with the reference product Soliris in ...
The Top 5 Biosimilar Articles for the Week of December 2 ...
Biosimilar SB17 demonstrated clinical biosimilarity to reference ustekinumab after switching and maintained long-term ...
The Top 5 Biosimilar Articles for the Week of December 2 ...
Three players in the biosimilar space have already sparked hope for the new year, with each having big business or regulatory ...
The Top 5 Biosimilar Articles for the Week of December 2 ...
A real-world study in adolescent and young adult patients with inflammatory bowel disease (IBD) found no significant ...
The Top 5 Biosimilar Articles for the Week of December 2 ...
Number 5: The 3 largest pharmacy benefit managers (PBMs) increased many specialty generic drugs prices by hundreds of percent, with some drugs seeing thousands of percent markups, according to the ...
When compared with reference aflibercept, a biosimilar ranibizumab was a clinically effective and cost-saving alternative in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback